A new @evaluatepharma report suggests that #biosimilars could erode sales of biologics by 54% in the coming years.… https://t.co/BRev3JCWoe
A new @evaluatepharma report suggests that #biosimilars could erode sales of biologics by 54% in the coming years.… https://t.co/BRev3JCWoe